Cargando…

The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone

SUMMARY: The risk of vertebral fracture is unclear in end-stage renal disease. We report a high vertebral fracture prevalence and incidence in transplantation-eligible patients on dialysis, suggesting that these patients may benefit from radiographic screening for vertebral fractures. Parathyroid ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansz, T. T., Goto, N. A., van Ballegooijen, A. J., Willems, H. C., Verhaar, M. C., van Jaarsveld, B. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076061/
https://www.ncbi.nlm.nih.gov/pubmed/31728605
http://dx.doi.org/10.1007/s00198-019-05187-0
_version_ 1783507146710712320
author Jansz, T. T.
Goto, N. A.
van Ballegooijen, A. J.
Willems, H. C.
Verhaar, M. C.
van Jaarsveld, B. C.
author_facet Jansz, T. T.
Goto, N. A.
van Ballegooijen, A. J.
Willems, H. C.
Verhaar, M. C.
van Jaarsveld, B. C.
author_sort Jansz, T. T.
collection PubMed
description SUMMARY: The risk of vertebral fracture is unclear in end-stage renal disease. We report a high vertebral fracture prevalence and incidence in transplantation-eligible patients on dialysis, suggesting that these patients may benefit from radiographic screening for vertebral fractures. Parathyroid hormone had a U-shaped association with vertebral fracture risk. INTRODUCTION: Vertebral fractures are often overlooked, but even undiagnosed vertebral fractures negatively impact physical functioning, quality of life, and mortality. The risk of vertebral fractures in end-stage renal disease (ESRD) patients is unclear, and parathyroid hormone (PTH) might play a role in the development of vertebral fractures. We therefore determined vertebral fracture prevalence and incidence in ESRD patients and assessed associations of vertebral trabecular bone mineral density (BMD) and PTH with vertebral fracture. METHODS: In 146 transplantation-eligible patients on dialysis, we determined vertebral fractures on lateral chest radiographs, which image the thoracic and upper lumbar spine. We determined incident vertebral fractures in 70 patients with follow-up radiographs (23 received a kidney transplant) after median 1.8 years. Vertebral trabecular BMD was measured with computed tomography, and PTH measured with 2-site immunoassays, categorized in tertiles with the middle tertile as reference. We used Poisson regression to assess associations of vertebral trabecular BMD and PTH with vertebral fracture. RESULTS: Mean age of the study population was 52 ± 13 years, and 98 (67%) were male. Median dialysis duration was 26 (IQR 13–55) months. Vertebral fractures were present in 50/146 patients (34%) and incident vertebral fractures occurred in 20/70 patients (29%). Vertebral trabecular BMD was not associated with vertebral fracture prevalence (relative risk 0.97, 95% CI 0.89 to 1.04). For the lowest PTH tertile (< 11 pmol/L), the relative risk of vertebral fracture was greater although not significant (2.28, 95% CI 0.97 to 5.97) and was significantly greater for the highest PTH tertile (≥ 30 pmol/L; 2.82, 95% CI 1.22 to 7.27) after adjustment for potential confounders. CONCLUSIONS: The prevalence and incidence of vertebral fractures is high even in relatively young and healthy ESRD patients. Vertebral trabecular BMD is not associated with vertebral fracture, and the association of PTH with vertebral fracture risk appears U-shaped. Nevertheless, our study did not measure vertebral BMD using DXA and assessed vertebral fractures using lateral chest radiographs and not spine radiographs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00198-019-05187-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7076061
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-70760612020-03-23 The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone Jansz, T. T. Goto, N. A. van Ballegooijen, A. J. Willems, H. C. Verhaar, M. C. van Jaarsveld, B. C. Osteoporos Int Original Article SUMMARY: The risk of vertebral fracture is unclear in end-stage renal disease. We report a high vertebral fracture prevalence and incidence in transplantation-eligible patients on dialysis, suggesting that these patients may benefit from radiographic screening for vertebral fractures. Parathyroid hormone had a U-shaped association with vertebral fracture risk. INTRODUCTION: Vertebral fractures are often overlooked, but even undiagnosed vertebral fractures negatively impact physical functioning, quality of life, and mortality. The risk of vertebral fractures in end-stage renal disease (ESRD) patients is unclear, and parathyroid hormone (PTH) might play a role in the development of vertebral fractures. We therefore determined vertebral fracture prevalence and incidence in ESRD patients and assessed associations of vertebral trabecular bone mineral density (BMD) and PTH with vertebral fracture. METHODS: In 146 transplantation-eligible patients on dialysis, we determined vertebral fractures on lateral chest radiographs, which image the thoracic and upper lumbar spine. We determined incident vertebral fractures in 70 patients with follow-up radiographs (23 received a kidney transplant) after median 1.8 years. Vertebral trabecular BMD was measured with computed tomography, and PTH measured with 2-site immunoassays, categorized in tertiles with the middle tertile as reference. We used Poisson regression to assess associations of vertebral trabecular BMD and PTH with vertebral fracture. RESULTS: Mean age of the study population was 52 ± 13 years, and 98 (67%) were male. Median dialysis duration was 26 (IQR 13–55) months. Vertebral fractures were present in 50/146 patients (34%) and incident vertebral fractures occurred in 20/70 patients (29%). Vertebral trabecular BMD was not associated with vertebral fracture prevalence (relative risk 0.97, 95% CI 0.89 to 1.04). For the lowest PTH tertile (< 11 pmol/L), the relative risk of vertebral fracture was greater although not significant (2.28, 95% CI 0.97 to 5.97) and was significantly greater for the highest PTH tertile (≥ 30 pmol/L; 2.82, 95% CI 1.22 to 7.27) after adjustment for potential confounders. CONCLUSIONS: The prevalence and incidence of vertebral fractures is high even in relatively young and healthy ESRD patients. Vertebral trabecular BMD is not associated with vertebral fracture, and the association of PTH with vertebral fracture risk appears U-shaped. Nevertheless, our study did not measure vertebral BMD using DXA and assessed vertebral fractures using lateral chest radiographs and not spine radiographs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00198-019-05187-0) contains supplementary material, which is available to authorized users. Springer London 2019-11-14 2020 /pmc/articles/PMC7076061/ /pubmed/31728605 http://dx.doi.org/10.1007/s00198-019-05187-0 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Jansz, T. T.
Goto, N. A.
van Ballegooijen, A. J.
Willems, H. C.
Verhaar, M. C.
van Jaarsveld, B. C.
The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone
title The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone
title_full The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone
title_fullStr The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone
title_full_unstemmed The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone
title_short The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone
title_sort prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076061/
https://www.ncbi.nlm.nih.gov/pubmed/31728605
http://dx.doi.org/10.1007/s00198-019-05187-0
work_keys_str_mv AT jansztt theprevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone
AT gotona theprevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone
AT vanballegooijenaj theprevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone
AT willemshc theprevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone
AT verhaarmc theprevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone
AT vanjaarsveldbc theprevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone
AT jansztt prevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone
AT gotona prevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone
AT vanballegooijenaj prevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone
AT willemshc prevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone
AT verhaarmc prevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone
AT vanjaarsveldbc prevalenceandincidenceofvertebralfracturesinendstagerenaldiseaseandtheroleofparathyroidhormone